超越思维和地中海饮食:设计饮食以优化帕金森病的结果
Laurie K Mischley1,2,3, Magdalena Murawska3
1Bastyr University Research Institute, Bastyr University, Kenmore, WA 98028, USA.
Nutrients
|July 30, 2025
概括
与MIND和地中海饮食相比,一种新的患者报告结果 (PRO) 饮食,PRO-21,显示出更好的预测帕金森病 (PD) 症状进展的能力. 较高的PRO-21饮食坚持与PD症状进展速度较慢有关.
科学领域:
- 神经学 神经学
- 营养科学 营养科学
- 流行病学 流行病学
背景情况:
- 饮食干预措施在管理帕金森病 (PD) 症状方面表现有前途.
- 现有的饮食尺度,如MIND和地中海 (MEDI) 饮食,在解释症状变化方面存在局限性.
- 从患者报告的结果 (PROs) 中确定特定的饮食模式对于个性化的PD管理至关重要.
研究的目的:
- 通过使用患者报告的结果,随着时间的推移,识别与PD症状最少相关的食物和饮食模式 (PRO饮食).
- 开发PRO饮食的复合坚持量表,并将其有效性与MIND和MEDI饮食量表进行比较.
- 评估PRO饮食遵守对PD症状进展轨迹的预测能力.
主要方法:
- 利用了前性纵向研究和帕金森症可修改变量 (MVP) 研究的数据.
- 通过使用预测模型和来自2290名PD患者的食物频率数据的代过程开发了PRO饮食.
- 使用回归模型和Akaike信息标准 (AIC) 对模型合适性进行比较,将PRO饮食量表 (PRO-21) 与MIND和MEDI量表进行比较.
主要成果:
- 与MIND (28,793.08) 和MEDI (28,897.24) 饮食相比,PRO-21饮食量表现出一个更好的模型匹配 (AIC:27,500.71).
- 在基线时更高的PRO-21饮食坚持与PD症状进展速度减缓43%有关.
- 无论是MIND还是MEDI饮食,都显示出类似的效果,非运动症状的影响是运动症状的影响的两倍.
结论:
- 在解释PD结果的差异方面,PRO-21饮食量表现明显优于MIND和MEDI饮食.
- 虽然PRO-21显示出卓越的预测能力,但其苛刻的性质可能会给成本,可行性和可持续性带来挑战.
- 未来的干预试验是必要的,以评估PRO-21饮食在帕金森病患者的实际可行性,坚持性和临床影响.
相关概念视频
01:24Parkinson's Disease: Treatment
381
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
381
01:15Parkinson's Disease: Overview
710
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
710
01:26Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
01:25Peritoneal Dialysis III: Nursing Management
146
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
146
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
422
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
422
01:37Neural Regulation
40.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.1K